Resources

Welcome to our searchable resource and literature collection on safer supply and related topics.

Found a broken link? Links do move around, so if you find one here that's broken, please let us know through the Contact form.

 

The implications of COVID-19 for people who use drugs (PWUD)

Highlight emerging risks linked to the COVID-19 pandemic for people who use drugs and those providing services for them from a European perspective, and encourages the planning, review and adaption of
Commentary | 2020
Harm reduction, About PWUD, Illegal drugs

The opioid death crisis in Canada: crucial lessons for public health

Look at public health lessons from the opioid crisis
Commentary | 2018
Mortality, Withdrawal, Evidence base, Policy/Regulatory, Advocacy, Illegal drugs

The release of abuse-deterrent OxyContin and adolescent heroin use

To determine the association between the abuse-deterrent reformulation of OxyContin and adolescent lifetime heroin use in the United States.
Original research | 2021
Evidence base, Illegal drugs, Youth

The State of Opioid Agonist Therapy in Canada 20 Years after Federal Oversight

During the more than 20 years since the federal health authority transferred oversight of methadone to the provincial level, methadone programming has evolved differently in every province
Commentary | 2017
Evidence base, Policy/Regulatory, Wrap-around services, Safer supply, Rural/remote, Substitution/OAT

The Structure, Growth, and Development of an Addiction Medicine & Rural Service

Slide deck | 2021
Clinical guidance, About prescribers, Small/medium cities

Trained Volunteers With Type 2 Diabetes Experience Significant Health Benefits When Providing Peer Support

Trained lay volunteers may have value in supporting lifestyle change programs in the prevention of type 2 diabetes, but the potential health benefits (or harms) experienced by these lay volunteers hav
Original research | 2021
Peer/PWLLE program involvement

‘Keeping a lid on it’: Exploring ‘problematisations’ of prescribed medication in prisons in the UK

The non-medical use of prescription medication and risk of diversion have become policy and practice concerns within prison settings in the UK.
Original research | 2022
Policy/Regulatory, Advocacy, About prescribers, Legal system/law enforcement, Diversion

‘Safer opioid distribution’ as an essential public health intervention for the opioid mortality crisis – Considerations, options and examples towards broad-based implementation

Commentary | 2020
Harm reduction, Policy/Regulatory, Safer supply

Advocating for diamorphine: Cosmopolitical care and collective action in the ruins of the ‘old British system’

Argue through the accounts of advocates and patients for the continuation of these flexible and hidden modes of caring with diamorphine as not merely a form of supporting individuals’ rights (to ca

Original research | 2020
Policy/Regulatory, Advocacy, Barriers and enablers

Bioequivalence Following Buccal and Sublingual Placement of Fentanyl Buccal Tablet 400μg in Healthy Subjects

FBT is indicated for the management of breakthrough pain (a transient flare of pain on a background of chronic pain otherwise controlled by treatment with opioids) in patients with cancer who are alre
Original research | 2008
Clinical guidance, About prescribers, Chronic pain

Can touch this: training to correct police officer beliefs about overdose from incidental contact with fentanyl

To better understand the potential of police education interventions in correcting false beliefs about fentanyl
Original research | 2021
Overdose, Legal system/law enforcement, Illegal drugs

Clinical Management of Cannabis Withdrawal

This review describes the diagnosis, prevalence, course and management of cannabis withdrawal and highlights opportunities for future clinical research.
Lit review | 2021
Withdrawal, Clinical guidance

Closed-loop wearable naloxone injector system

There remains a critical need for technologies to administer naloxone in the event of unwitnessed overdose events.
Original research | 2021
Overdose, Harm reduction, Illegal drugs, Digital health

Comparison of Equivalent Doses of Fentanyl Buccal Tablets and Arteriovenous Differences in Fentanyl Pharmacokinetics

Assess whether 4x100μg fentanyl buccal tablets had the same biological effect as 1 400μg tablet
Original research | 2006
Clinical guidance, About prescribers

Consumer protection in drug policy: The human rights case for safe supply as an element of harm reduction

Examines the human rights justification for incorporating safe supply as an important element of the HR pillar of drug policy.
Commentary | 2020
Policy/Regulatory, Safer supply, Advocacy, Illegal drugs, Peer/PWLLE program involvement

Decolonizing drug policy

This paper reviews evidence of how drug control has been used to uphold colonial power structures in select countries.
Scoping review | 2021
Policy/Regulatory, Safer supply, Decriminalization/legalization, Equity, Advocacy, Social services, Illegal drugs

Drug risk perception and risk management strategies among Israeli functioning drug users: a qualitative exploration

Examining how functioning people who are in the process of building their careers or family lives perceive and manage the risks and harms of drug use.
Original research | 2021
Harm reduction, About PWUD, Illegal drugs

Drug risk perception and risk management strategies among Israeli functioning drug users: a qualitative exploration

Examines how functioning people who are in the process of building their careers or family lives perceive and manage the risks and harms of drug use
Original research | 2021
Harm reduction, About PWUD, Illegal drugs, Social benefits

Emergency department presentations in the first weeks following release from prison among men with a history of injecting drug use in Victoria, Australia: A prospective cohort study

Rates of emergency department (ED) use are higher among people released from prison than in the general population.
Original research | 2022
Harm reduction, About PWUD, Social services, Outcomes, Housing, Legal system/law enforcement, Illegal drugs, Sex/Gender , Mental health, Hospitals

Exposure to fentanyl-contaminated heroin and overdose risk among illicit opioid users in Rhode Island: A mixed methods study

This study describes patterns and perceptions of fentanyl exposure among opioid users in Rhode Island.
Original research | 2017
Evidence base, Harm reduction, Safer supply, Illegal drugs

Refine Your Search

Keywords
Format
Region